UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers

Cancer epidemiology, biomarkers & prevention, 2014, Vol.23 (1), p.144-153

2014

Volltextzugriff (PDF)

Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial

Hepatology communications, 2024-05, Vol.8 (5)

2024

Volltextzugriff (PDF)

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2012-04, Vol.16 (2), p.172-184

2012

Volltextzugriff (PDF)

Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver Cancer

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1546-1552

2004

Volltextzugriff (PDF)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

Journal of hepatology, 2016-02, Vol.64 (2), p.399-408

2016

Volltextzugriff (PDF)

Nanotechnology Environmental Health and Safety - Risks, Regulation and Management

Second Edition., 2014

Volltextzugriff (PDF)

Clinical trial: physical, psychological and social needs of patients

British journal of nursing (Mark Allen Publishing), 2013-01, Vol.22 (2), p.76-80

Hull, Diana

2013

Volltextzugriff (PDF)

THU-160 Long-term variability of pruritus in primary sclerosing cholangitis and implications for future clinical trial design

Journal of hepatology, 2024-06, Vol.80, p.S332-S332

2024

Volltextzugriff (PDF)

Nanotechnology Environmental Health and Safety - Risks, Regulation, and Management (3rd Edition)

Third edition., 2018

Volltextzugriff (PDF)

Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study

Journal of hepatology, 2023-06, Vol.78, p.S398-S399

2023

Volltextzugriff (PDF)

WED-299 - Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study

Journal of hepatology, 2023-06, Vol.78, p.S398-S399

2023

Volltextzugriff (PDF)

PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK

Supportive care in cancer, 2024-03, Vol.32 (3), p.199-199, Article 199

2024

Volltextzugriff (PDF)

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

The lancet. Gastroenterology & hepatology, 2018-01, Vol.3 (1), p.25-36

2018

Volltextzugriff (PDF)

A randomised phase II clinical trial of low-dose cyclophosphamide and transarterial chemoembolization (TACE) with or without vaccination with dendritic cells (DC) pulsed with HepG2 lysate ex vivo in patients with hepatocellular carcinoma (HCC): The ImmunoTACE trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4012-4012

2022

Volltextzugriff (PDF)

A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]

Molecular therapy, 2009-07, Vol.17 (7), p.1292-1299

2009

Volltextzugriff (PDF)

A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984

Molecular therapy, 2009-07, Vol.17 (7), p.1292-1299

2009

Volltextzugriff (PDF)

Rigid-Rod Polyimides Based on Noncoplanar 4,4‘-Biphenyldiamines: A Review of Polymer Properties vs Configuration of Diamines

Macromolecules, 1997-11, Vol.30 (23), p.7183-7190

1997

Volltextzugriff (PDF)

Nanotechnology Environmental Health and Safety: Risks, Regulation and Management

Matthew Hull, Diana Bowman

2009

Volltextzugriff (PDF)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

BMJ open, 2013-11, Vol.3 (11), p.e003995-e003995

2013

Volltextzugriff (PDF)

Effect of liraglutide on adipose insulin resistance and hepatic de-novo lipogenesis in non-alcoholic steatohepatitis: substudy of a phase 2, randomised placebo-controlled trial

The Lancet (British edition), 2014-02, Vol.383, p.S21-S21

2014

Volltextzugriff (PDF)

Nanotechnology Environmental Health and Safety

2009

Volltextzugriff (PDF)

Patient and public involvement to support liver disease research

British journal of nursing (Mark Allen Publishing), 2012-09, Vol.21 (16), p.972-976

2012

Volltextzugriff (PDF)

Opportunities to participate in clinical trials: awareness among liver patients

Gastrointestinal nursing, 2018-02, Vol.16 (1), p.30-35

2018

Volltextzugriff (PDF)

Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study

International journal of palliative nursing, 2010-05, Vol.16 (5), p.249-254

2010

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(110)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Nanotechnology
(53)
Humans
(41)
Life Sciences & Biomedicine
(38)
Environmental Nanotechnology & Environmental Safety
(36)
Male
(27)
Adult
(17)
Female
(17)
Middle Aged
(16)
Aged
(11)
Science & Technology - Other Topics
(11)
Clinical Trials
(9)
Environmental Factors
(9)
Nanoscience & Nanotechnology
(8)
Endocrinology & Metabolism
(7)
General & Internal Medicine
(7)
Nursing
(7)
Patients
(7)
Safety
(7)
Administration, Oral
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers

Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group

Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver Cancer

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

Nanotechnology Environmental Health and Safety - Risks, Regulation and Management

Clinical trial: physical, psychological and social needs of patients

THU-160 Long-term variability of pruritus in primary sclerosing cholangitis and implications for future clinical trial design

Nanotechnology Environmental Health and Safety - Risks, Regulation, and Management (3rd Edition)

Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study

WED-299 - Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study

PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK

LBP-046 A phase IIa basket clinical trial of allogeneic CD362-enriched umbilical cord-derived mesenchymal stromal cells (ORBCEL-CTM) in patients with primary sclerosing cholangitis and autoimmune hepatitis

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

A randomised phase II clinical trial of low-dose cyclophosphamide and transarterial chemoembolization (TACE) with or without vaccination with dendritic cells (DC) pulsed with HepG2 lysate ex vivo in patients with hepatocellular carcinoma (HCC): The ImmunoTACE trial

A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]

A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984

Rigid-Rod Polyimides Based on Noncoplanar 4,4‘-Biphenyldiamines: A Review of Polymer Properties vs Configuration of Diamines

Nanotechnology Environmental Health and Safety: Risks, Regulation and Management

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

Effect of liraglutide on adipose insulin resistance and hepatic de-novo lipogenesis in non-alcoholic steatohepatitis: substudy of a phase 2, randomised placebo-controlled trial

Nanotechnology Environmental Health and Safety

Patient and public involvement to support liver disease research

Opportunities to participate in clinical trials: awareness among liver patients

Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study

Suchergebnisse filtern